For Cancer Crosslinks 2020, Oslo Cancer Cluster is gathering a distinguished panel of international and Norwegian experts to present and discuss recent progress in precision treatment and cancer immunotherapy.
This meeting will promote interactions between researchers and clinicians to further enhance translational and clinical research and encourage new collaborations to advance the development of innovative cancer treatments.
The hallmark of Cancer Crosslinks is the full-day educational program focusing on recent advances in oncology. The day program is complemented by tailored activities to stimulate additional interactions and discussions between the Cancer Crosslinks speakers and representatives from the Norwegian oncology community.
Confirmed international speakers include:
- Michel Sadelain, Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, USA
- Jason J. Luke, Director of the Cancer Immunotherapeutics Center, Associate Professor of Medicine, University of Pittsburgh Medical Center and Hillman Cancer Center, USA
- Stefani Spranger, Howard S. and Linda B. Stern Career Development, Assistant Professor, Koch Institute for Integrative Cancer Research at MIT, Cambridge, USA
- Maria Victoria Mateos, Associate Professor of Hematology and Consultant Physician in the Haematology Department, Director of the Myeloma Unit, University of Salamanca, Spain
Registration will open October 2019. The program and speaker updates will be available during autumn.
For more information about the program, please contact:
Jutta Heix, Head of International Affairs, firstname.lastname@example.org or Charlotte Homme, Head of Membership & Events, email@example.com
This event is supported by: